Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Active not recruiting 3Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Breast 1

Conditions

Ovarian Neoplasms 2Hereditary Breast and Ovarian Cancer Syndrome 1

Interventions

pembrolizumab 45Paclitaxel 45Carboplatin 39Magnetic Resonance Spectroscopy 28olaparib 27Specimen Handling 26Cisplatin 24Bevacizumab 20Nivolumab 18Taxes 17Biopsy 16Gemcitabine 13Cyclophosphamide 13durvalumab 12Immunoglobulin G 11Doxorubicin 11Disulfides 11Surveys and Questionnaires 10niraparib 9liposomal doxorubicin 9dostarlimab 9Radiotherapy 8Brachytherapy 8lenvatinib 7fludarabine 7atezolizumab 7Letrozole 7Docetaxel 7cediranib 6Platinum 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Salpingectomy × Gynecologic × Clear all
NCT03045965 2026-02-17

HOPPSA

Göteborg University

Phase NA Active not recruiting
4,400 enrolled
Gynecologic

Ovarian Neoplasms

NCT02760849 2026-01-07

Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations

M.D. Anderson Cancer Center

Phase NA Active not recruiting
374 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

NCT02321228 2024-12-05

TUBA

University Medical Center Nijmegen

Phase NA Active not recruiting
510 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡